Lion’s mane (Hericium erinaceus) is a culinary and medicinal mushroom with distinctive cascading white spines. It contains two families of bioactive compounds: hericenones concentrated in the fruiting body and erinacines concentrated in the mycelium. Both compound families cross the blood-brain barrier and stimulate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), with preclinical evidence supporting neurogenesis, myelin regeneration, and neuroprotection.
Clinical evidence for cognitive indications is promising but limited. A landmark Japanese RCT (Mori et al., 2009) in older adults with mild cognitive impairment showed significant cognitive score improvement over 16 weeks with 3g daily lion’s mane powder, with benefit disappearing after discontinuation. Smaller studies support mood benefit and reduced symptoms of depression and anxiety. Effect sizes are modest (SMD 0.3-0.5) and time to effect is 4-12 weeks, consistent with proposed neurotrophic mechanism rather than acute neurotransmitter modulation.
Product quality matters substantially. Dual-extracted products (hot water and alcohol extraction, to capture both water-soluble polysaccharides and alcohol-soluble triterpenes) from the fruiting body are preferred. Many commercial products contain only mycelium grown on grain, with the grain substrate counted in the product weight, producing substantially lower active compound content than labeled. Look for products with beta-glucan content verified by third-party testing. Breastfeeding safety data are insufficient, so conditional use is recommended for postpartum indications, and we position lion’s mane as an optional addition rather than a foundation intervention.